Patents by Inventor Srirupa Das

Srirupa Das has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8507465
    Abstract: The present invention relates to a method of reducing the incidence of nausea and vomiting associated with the administration of oral contraceptive formulation and a method of preparation of oral contraceptive formulation comprising progestin and/or estrogen and an antiemetic. The preferred oral contraceptive formulation comprises of levonorgestrel and an antiemetic.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: August 13, 2013
    Assignee: Lupin Limited
    Inventors: Sheetal Kulkarni, Srirupa Das, Harshal Anil Jahagirdar, Satish Dalal, Shirish Kulkarni
  • Publication number: 20110003837
    Abstract: Modified release formulations of HMG Co-A reductase inhibitors, which provide reduced incidence of rhabdomyolysis, renal toxicity and other side effects by increasing hepatic bioavailability and decreasing systemic availability upon oral administration. The modified release pharmaceutical formulation comprises a therapeutically effective amount of HMG CoA reductase inhibitor or a pharmaceutically acceptable salt(s), polymorph(s), solvate(s), hydrate(s), prodrug or metabolite thereof, one or more release modifying agent(s) and one or more pharmaceutically acceptable excipient(s), wherein the modified release formulation provides reduced incidence of adverse effects and improved efficacy when compared to the immediate release formulation upon oral administration.
    Type: Application
    Filed: January 30, 2009
    Publication date: January 6, 2011
    Applicant: LUPIN LIMITED
    Inventors: Sheetal KULKARNI, Srirupa DAS, Ashish Ashokrao DESHMUKH, Satish Kumar DALAL, Shirishkumar KULKARNI
  • Publication number: 20100240626
    Abstract: The present invention relates to a method of reducing the incidence of nausea and vomiting associated with the administration of oral contraceptive formulation and a method of preparation of oral contraceptive formulation comprising progestin and/or estrogen and an antiemetic. The preferred oral contraceptive formulation comprises of levonorgestrel and an antiemetic.
    Type: Application
    Filed: October 24, 2008
    Publication date: September 23, 2010
    Applicant: Lupin Limited
    Inventors: Sheetal Kulkarni, Srirupa Das, Harshal Jahagirdar, Satish Dalal, Shirish Kulkarni